Addrenex Pharmaceuticals Acquired by Sciele Pharma for $29 Million

View All News
Mergers & Acquisitions

Addrenex Pharmaceuticals Acquired by Sciele Pharma for $29 Million

Addrenex Pharmaceuticals, a drug development company based in Durham and a Hutchison Law Group client, was recently acquired by Sciele Pharma for $29 million dollars.

Hutchison Law Group, along with Leerink Swann, served as advisors to Addrenex in the transaction. 

More details are available online through the Triangle Business Journal and the News & Observer.